Evidence map›Paper›PMID 41034399›Full record

ArticleActa pharmacologica Sinica2026

Harnessing deep statistical potential for biophysical scoring of protein-peptide interactions.

De-Jun Jiang, Hui-Feng Zhao, Hong-Yan Du, Yu Kang, Pei-Chen Pan, Zhen-Xing Wu, Yun-Dian Zeng, O-Din Zhang, Xiao-Rui Wang, Ji-Ke Wang and 6 more

Abstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

De-Jun Jiang *College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Hui-Feng Zhao *College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Hong-Yan Du *College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Yu KangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Pei-Chen PanCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Zhen-Xing WuCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Yun-Dian ZengCollege of Control Science and Engineering, Zhejiang University, Hangzhou, 310058, China.
O-Din ZhangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Xiao-Rui WangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Ji-Ke WangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Yuan-Sheng HuangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Yi-Hao ZhaoCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Chang-Yu HsiehCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. kimhsieh@zju.edu.cn.
Dong-Sheng CaoXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410004, China. oriental-cds@163.com.
Hui-Yong SunDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 210009, China. huiyongsun@cpu.edu.cn.
Ting-Jun HouCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. tingjunhou@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-peptide interactions (PpIs) play a critical role in major cellular processes. Recently, a number of machine learning (ML)-based methods have been developed to predict PpIs, but most of them rely heavily on sequence data, limiting their ability to capture the generalized molecular interactions in three-dimensional (3D) space, which is crucial for understanding protein-peptide binding mechanisms and advancing peptide therapeutics. Protein-peptide docking approaches provide a feasible way to generate the 3D models of PpIs, but they often suffer from low-precision scoring functions (SFs). To address this, we developed DeepPpIScore, a novel SF for PpIs that employs unsupervised geometric deep learning coupled with a physics-inspired statistical potential. Trained solely on curated experimental structures without binding affinity data or classification labels, DeepPpIScore exhibits broad generalization across multiple tasks. Our comprehensive evaluations in bound and unbound peptide bioactive conformation prediction, binding affinity prediction, and binding pair identification reveal that DeepPpIScore outperforms or matches state-of-the-art baselines, including popular protein-protein SFs, ML-based methods, and AlphaFold-Multimer 2.3 (AF-M 2.3). Notably, DeepPpIScore achieves superior results in peptide binding mode prediction compared to AF-M 2.3. More importantly, DeepPpIScore offers interpretability in terms of hotspot preferences at protein interfaces, physics-informed noncovalent interactions, and protein-peptide binding energies.

Indexed as

Deep LearningPeptidesProteinsMachine LearningMolecular Docking SimulationProtein BindingPeptidesProteinsAlphaFoldgeometric deep learningprotein-peptide interactionsscoring functionstatistical potential

Identifiers

PMID41034399
PMCPMC12811297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.